or symptoms in patients July 2013, with primary deferred in Up to no July 2014, June Dec Ruxolitinib Jakavi® Aus 11 Yes 15 no funding no funding per 2013 2014 no in vera year funding March 2015, or listed Feb 2016
Ruxolitinib Jakavi® Aus 11 Yes or symptoms in patients with primary vera or 15 Up to per year June 2013 July 2013, deferred in July 2014, in March 2015, listed Feb 2016 no funding Dec 2014 no funding no no funding